12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Other News

Glenmark, Merck & Co Inc., Sun Pharmaceutical endocrine/metabolic news

Merck said the Indian High Court of Delhi refused to grant an injunction preventing Glenmark's launch of generic versions of diabetes drugs Januvia sitagliptin and Janumet sitagliptin/metformin in India. Merck said it has...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >